Evolent Health Inc [EVH] stock prices are saw in change for the day to $4.2 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EVH shares have gain 13.82% over the last week, with a monthly amount drifted -40.68%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on November 13, 2025, when Stephens upgraded its rating to an Overweight but kept the price target unchanged to $7 for it. Previously, BMO Capital Markets started tracking the stock with Outperform rating on November 13, 2025, and set its price target to $7. On January 10, 2025, Needham initiated with a Buy rating and assigned a price target of $15 on the stock. BTIG Research reiterated its Buy rating and decreased its price target to $29 on December 03, 2024. Stephens downgraded its rating to a Equal-Weight and reduced its price target to $16 on November 08, 2024. KeyBanc Capital Markets started tracking with an Overweight rating for this stock on October 11, 2024, and assigned it a price target of $35. In a note dated August 09, 2024, Truist upgraded a Buy rating on this stock and boosted its target price from $28 to $33.
The stock price of Evolent Health Inc [EVH] has been fluctuating between $3.49 and $13.61 over the past year. Currently, Wall Street analysts expect the stock to reach $31.11 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $4.2 at the most recent close of the market. An investor can expect a potential return of 640.71% based on the average EVH price forecast.
Analyzing the EVH fundamentals
The Evolent Health Inc [NYSE:EVH] reported sales of 2.05B for trailing twelve months, representing a drop of -22.83%. Gross Profit Margin for this corporation currently stands at -0.06% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.15 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.14 points at the first support level, and at 4.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.28, and for the 2nd resistance point, it is at 4.35.
Ratios To Look Out For
It’s worth pointing out that Evolent Health Inc [NYSE:EVH]’s Current Ratio is 1.33. As well, the Quick Ratio is 1.33, while the Cash Ratio is 0.27. Considering the valuation of this stock, the price to sales ratio is 0.23, the price to book ratio is 0.56.
Transactions by insiders
Recent insider trading involved Springstubb Brendan B, Director, that happened on Nov 18 ’25 when 10000.0 shares were purchased. Director, Holder Diane completed a deal on Mar 06 ’25 to buy 2735.0 shares. Meanwhile, PRESIDENT McCarthy Daniel Joseph bought 11040.0 shares on Mar 06 ’25.
